Philip S Rudland
Affiliations: | Biochemistry | University of Liverpool, LIVERPOOL, UK. |
Google:
"Philip Rudland"Mean distance: (not calculated yet)
Children
Sign in to add trainee| David G Fernig | post-doc | 1988-1991 | University of Liverpool, LIVERPOOL, UK. |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ismail TM, Crick RG, Du M, et al. (2023) Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells. Biomolecules. 13 |
| Du M, Wang G, Barsukov IL, et al. (2020) Direct interaction of metastasis-inducing S100P protein with tubulin causes enhanced cell migration without changes in cell adhesion. The Biochemical Journal |
| Al-Jameel W, Gou X, Jin X, et al. (2019) Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ. Genes & Cancer. 10: 80-96 |
| Naeem AA, Abdulsamad SA, Rudland PS, et al. (2019) Fatty acid-binding protein 5 (FABP5)-related signal transduction pathway in castration-resistant prostate cancer cells: a potential therapeutic target Precision Clinical Medicine. 2: 192-196 |
| Dakir EH, Pickard A, Srivastava K, et al. (2018) The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer. Oncotarget. 9: 34889-34910 |
| Kamal A, Valentijn A, Barraclough R, et al. (2018) High AGR2 protein is a feature of low grade endometrial cancer cells. Oncotarget. 9: 31459-31472 |
| Tabrizi MEA, Lancaster TL, Ismail TM, et al. (2018) S100P enhances the motility and invasion of human trophoblast cell lines. Scientific Reports. 8: 11488 |
| Zakaria R, Platt-Higgins A, Rathi N, et al. (2017) T cell densities in brain metastases are associated with patient survival times and diffusion tensor MRI changes. Cancer Research |
| Clarke C, Gross SR, Ismail TM, et al. (2017) Activation of tissue plasminogen activator by metastasis-inducing S100P protein. The Biochemical Journal |
| Chan KK, Matchett KB, Coulter JA, et al. (2017) Erythropoietin drives breast cancer progression by activation of its receptor EPOR. Oncotarget |